Ymer Antibody Blocking Peptide

• Applications: AC
• Concentration: 1 mg/ml

Ymer Antibody Blocking Peptide Summary

• Specificity: This peptide is specific for NBP2-24483 only.
• Protein/Peptide Type: Antibody Blocking Peptide
• Gene: CCDC50

Applications/Dilutions

• Dilutions:
  • Antibody Competition
• Application Notes: This peptide is useful as a blocking peptide for NBP2-24483. For further blocking peptide related protocol, click here.

Packaging, Storage & Formulations

• Storage: Store at -80C. Avoid freeze-thaw cycles.
• Buffer: Peptide dissolved in dH20. Contains no BSA.
• Preservative: No Preservative
• Concentration: 1 mg/ml

Alternate Names for Ymer Antibody Blocking Peptide

• C3orf6deafness, autosomal dominant 44
• coiled-coil domain containing 50
• coiled-coil domain-containing protein 50
• DFNA44
• Protein Ymer
• Ymer

Background

Ymer encodes a soluble, cytoplasmic, tyrosine-phosphorylated protein with multiple ubiquitin-interacting domains. Mutations in this gene cause nonsyndromic, postlingual, progressive sensorineural DFNA44 hearing loss. In mouse, the protein is expressed in the inner ear during development and postnatal maturation and associates with microtubule-based structures. This protein may also function as a negative regulator of NF-kB signaling and as an effector of epidermal growth factor (EGF)-mediated cell signaling. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq]

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.

Bioinformatics

• Gene Symbol: CCDC50